Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- Medical firm thrives under Hainan's tax incentives
- China's homegrown MA60 civil search and rescue aircraft completes first test flight
- Xi receives credentials of new ambassadors to China
- Humans and AI monitor nuclear power plant construction around the clock
- Nuclear energy heating project to expand service coverage
- Cultural tourism brings vitality to old town in Xinjiang
